期刊文献+

偏倚风险评估工具在针刺Cochrane系统评价中的应用 被引量:20

Application of Risk of Bias Tool in Cochrane Systematic Reviews on Acupuncture
原文传递
导出
摘要 目的客观评价偏倚风险评估工具在针刺Cochrane系统评价(CSR)的应用情况。方法全面检索Cochrane系统评价数据库(2011年第12期),查找有关针刺的CSR。由2位研究者根据纳入与排除标准独立筛选文献、提取资料,然后进行统计分析。结果共纳入41个CSR。其中有19个为更新的系统评价,33个发表于2009~2011年间;60.98%报告采用了CochraneHandbook评估纳入研究偏倚风险/方法学质量;所有研究均评价了随机序列、分配隐藏及盲法信息,但未完整报告施盲对象;54.55%的研究分别报告了选择性报告偏倚和其他偏倚来源。结论大多数CSR选择使用CochraneHandbook推荐的偏倚风险评估工具评估纳入研究的偏倚风险,但依然有评估条目报告不完整的问题存在。 Objective To evaluate whether and to what extent the new risk of bias (ROB) tool has been used in Cochrane systematic reviews (CSRs) on acupuncture. Methods We searched the Cochrane Database of Systematic Review (CDSR) in issue 12, 2011. Two reviewers independently selected CSRs which primarily focused on acupuncture and moxibustion. Then the data involving in essential information, the information about ROB (sequence generation, allocation concealment, blindness, incomplete outcome data, selective reporting and other potential sources of bias) and GRADE were extracted and statistically analyzed. Results In total, 41CSRs were identified, of which 19 CSRs were updated reviews. Thirty-three were published between 2009 and 2011.60.98% reviews used the Cochrane Handbook as their ROB assessment tool. Most CSRs gave information about sequence generation, allocation concealment, blindness, and incomplete outcome data, however, half of them (54.55%, 8/69) showed selective reporting or other potential sources of bias. Conclusion "Risk of bias" tools have been used in most CSRs on acupuncture since 2009. However, the lack of evaluation items still remains.
出处 《中国循证医学杂志》 CSCD 2014年第3期361-364,共4页 Chinese Journal of Evidence-based Medicine
基金 国家自然科学基金项目--针刺系统评价/Meta分析报告指南制订方法的研究(编号:81373882)
关键词 偏倚风险 系统评价 针刺 Risk of bias Systematic review Acupuncture
  • 相关文献

参考文献21

  • 1杨声坪,闫先侠,刘建强,杨克虎,袁金秋,刘雅莉.随机对照试验质量评价标准的比较分析[J].循证医学,2010,10(6):369-373. 被引量:15
  • 2Higgins JPT, Green S. Cochrane Handbook for Systematic Re-views of Interventions. Version 5.1. 0 [updated March 2011]. TheCockraae Collaboration. Available at: www.cochraae-handbook.org. 2008.
  • 3LiuY, Yang S, Dai J, et al Risk of bias tool in systematic reviews/meta-analyses of acupuncture in Chinese Journals. PLoS Oney 2011,6(12): e28l30.
  • 4Ferreim CA, Loureito CAS, Saconato H, et al. Assessing the risk ofbias in randomized cohtroUed trials in tiie field of dentistrjr indexedin the Ulacs (Literatura Latino-Americana e do Caribe em Ci^nciasSadde) database. SmPauh Med /, 2011,129(2): 85-93.
  • 5Crocetti MT, Amin DD, Scherer K. Assessment of risk of bias amongpedtok: random^d controlled trials. P&UatrkSt 2010,126(2): 298-305.
  • 6Moher D, Jadad AK, Nichol G, et al. Assessing the quality of rwi-domized controlled trials: an annotated bibliography of scales andcheddists. Control Clin Trials^ 1995,16(1): 62-73.
  • 7Moher D, Jadad AR, Tugwell P. Assessing the quality of randomizedcontrolled trials: current issues and future directions. Int J TechnolAssess Health Care、1996,12(02): 195-208.
  • 8Jiini P, Altman DG, Bg^er M. S^tematic reviews in heaMi tare: Assess-the quality of controlled clinical trials, BMJ、2001,323(7303): 42-46.
  • 9Detsky AS, Naylor CD, CVRmirke K, et al. Incorporating variationsin the quality of indMdud randomized trials into meta-analysis. /Clin Epidemiol 1992,45(3): 255^265.
  • 10Verhagcn AP, De Vet HCW, De Bie RA, et al. The Delphi list; acriteria list for quality assessment of randomized clinical trials forconducting systematic reviews developed by Delphi consensus. /ClinBpidemiok 1998,51(12): 1235-1241.

二级参考文献66

  • 1Byar DP,Simon RM,Friedewald WT,et al.Randomized clinical trials perspectives on some recent ideas[J].N Engl J Med,1976,295(5):74-80.
  • 2Chalmers TC.Smith H Jr,Blackburn B,et M.A method for assessing the quality of a randomized control trial[J].Contwl Clin Trials.1981,2(1):31-49.
  • 3Weintranb Appmisal Tool[EB/OL].[2009-7].http://ssrc.tums.ac.ir/SystematieReview/Weintraub.asp.
  • 4Thomson Appraisal Tool[EB/OL].[2009-7].http://sarc.rums.ac.ir/SystematicReview/Thomson.asp.
  • 5Mary Evans Appraisal Tool[EB/OL].[2009-7].http://ssrc.tums.ac.ir/SystematicReview/Evans.asp.
  • 6Bland JM.Jones DR,Bennett S,et al.Is the clinicM trial evidence about new drugs statistically adequate?[J].Br J Glin Pharmacol,1985,19(2):155-160.
  • 7G.Ter Pdet Appraisal Tool[EB/OL].[2009-7].http://ssrc.tums.ac.ir/SystematicReview/GTerRiet.asp.
  • 8Detsky AS,Naylor CD,O'Rourke K,et al.Incorporating variations in the quality of individusl randomized triah into meta-analysis[J].J Clin Epidemiol,1992,45(3):255-265.
  • 9Beckeman H,de Bie RA,Bouter LM.et al.The efficacy of laser therapy for muscu,loskeletal and skin disorders:A eriteria-based meta-analysis of randomized clinical trials[J].Phys Ther.1992.72(7):483-491.
  • 10Numohamed Appraisal Tool[EB/OL].[2009-7].http://ssrc.tums.ac.ir/SystematicReview/Nurrnohamed.asp.

共引文献188

同被引文献353

引证文献20

二级引证文献134

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部